APPLICATION
ANDA219236
TYPE
ANDA
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)
Products
OZANIMODNone (Tentative Approval)
OZANIMOD 0.23MG · CAPSULE
OZANIMODNone (Tentative Approval)
OZANIMOD 0.46MG · CAPSULE
Approval history
2025-07-22UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.